INTRODUCTION
Markers of bone nmarro-w-dependent (B)l cells in imianl have been identifie(l in both the bone marrow (1) and peripheral blood (2) comlpartments an(l are universally accel)ted to be surface immtilunoglobuliiis (Ig) . B cells are not in a stattic state but undergo changes upon maturationi, migration between the various lynmphoid conmpartnments. aind upon interaction with the specific antigen (3, 4) .
Subpopulations of B cells have recently been described in the mlouse system and were proposed to represent various degrees of mlaturation of the B cell systeim (5) . Recent studies have indicated that B cell development wvithin the stemn cell conmpartment is independent of antigen stimulation (6) and that 1gM\-B cells control the differentiation of both IgG and IgA cells (7) and are the maiin recognition units (8) . (12) * Serum antibody titers by the hemagglutination technique were assayed 10 days following injection of diphtheria-tetanus toxoid. Number of patients is in parentheses. t 1 mg Keyhole limpet hemocyanin (KLH) was used for primary sensitization. Serum anti-KLH titers were determined on the 10th day by the passive hemagglutination technique. § Patients were skin tested with PPD, Candida albicans (Hollister-Stier), and mumps (Eli Lilly). Induration was read 48 h later. Numbers shown are those of patients who showed positive skin test (> 10 mm) to at least one of the three antigens.
11 Sensitization done with 0.1 ml of 5% solution of dinitrochlorobenzene (DNCB) and followed 2 wk later by challenge with 0.1 ml of 0.005% solution of DNCB. Skin induration (>10 mm) 48 h following challenge was considered positive.
and blood compartments of patients with infantile agammaglobulinemia (I-AGG) to cells obtained from patients with acquired agammaglobulinemia (A-AGG) and to search for possible etiologic factors that could be responsible for the B cell abnormalities.
METHODS
Patients. Patients' data are summarized in Table I . Two groups of patients were studied: (a) Three cases of I-AGG; boys age 2, 3, and 6 yr who had low Ig levels in their serum, using the low level commercial immunoplates. They were first diagnosed at age 9-12 mo. They had repeated respiratory tract and skin infections and were maintained on monthly GG injections. (b) Seven cases age 24-51 yr, with A-AGG. They had normal infancy and childhood and 2-14 yr history of repeated sinupulmonary and skin infections. Five of those seven cases had recurrent diarrhea, and four of those had biopsy evidence of intestinal lymphoid hyperplasia. (c) Controls were 12 patients with iron deficiency anemia: hemoglobin 9.5-11.2 g matched for the age of the patients with AGG, without history of repeated infections and had serum Ig levels within the normal range. None of the patients in the three groups described, had abnormal values of total hemolytic complement or of the third component of complement (C3). Serum antibody responses 10 days following sensitization with a primary antigen, Keyhole limpet hemocyanin, KLH (Pacific Bio-Marine Supply Co., Venice, Calif.) and to secondary antigens, tetanus-diphtheria toxoid (Wyeth Laboratories, Marietta, Pa.) were evaluated (Table I) (1, 8, 10) . Briefly, bone marrow aspirates or peripheral blood were collected in heparinized plastic syringes and lymphocyte rich (79-92%o) suspensions were prepared by means of sucrose plasma linear density gradients (8) . In all the experiments described 10 ,ug or 100 ,ug of light chain-absorbed, goat anti-human heavy chain-specific Ig antisera were added to 108 lymphocytes suspended in 1 ml medium 199 containing 10%o GG-free pooled human AB serum (10) .
Iodination of anti-Ig antisera. The techniques of iodination and binding of the ["I]anti-Ig to cells have been described previously (10) . Briefly 1 mg of the anti-Ig or normal goat GG (NGGG) was allowed to interact for 5 min with 1 mCi of 'I (International Chemical and Nuclear Corp., Irvine, Calif.) in the presence of Chloramine-T (11) . Following exhaustive adsorption of 10 ml of the various patients' or control sera, the columns were eluted w-ith 20-50 ml of 0.1 M glycine HCI, the material is theni concentrated to 1 ml and examined for the presence of Ig using the low level Ig quanti-plates (Kallestad Laboratories). The amounits of the anti-Ig were expressed as mg/100 ml of the original serum sample.
Stuidics of elided anti-Igs. The binding capacity of the eluted anti-It to cells was tested by incubating the eluted material with peripheral blood lymphocytes of controls. 10 or 100 ag of the eltited material was incubated under continluous rotation for 1 h at 4°C with 106 lymphocytes. Cells were then washed three times with medium 199 containing 10% GG-free plasma. The presence of Ig recel)tors on the washed cells xvas then examined by the capacity of cells to bind to the radiolabeled anti-Ig or be stained w-ith the fluorescinate(l anti-Ig as described above. Viability studies Table I shows that both the primary and secondary serum antibody responses in both types of AGG were poor. Cell-mediated immunity as expressed by induration following skin testing with primary or secondary antigens, on the other hand, were comparable to controls. Table II shows the binding capacity of bone marrow or blood lymphocytes to the iodinated anti-IgM, antiIgG, or anti-IgA. It could be seen that both BM and PB cells from I-AGG patients failed to bind to any of the three labeled antisera as compared with control cells (P < 0.01). There were no differences between the binding capacity of BM cells of A-AGG patients to that of control BM cells. The binding capacity of PB cells of A-AGG patients, however, was poor as compared with controls (P < 0.01). Moreover the binding of ['I]anti-IgM to blood lymphocytes of A-AGG patients was significantly lower than that to bone marrow cells of the same patients or to the controls (P < 0.01).
In Table III is shown the results of staining both bone marrow or blood lymphocytes with fluorescinated Table) .
In Table V is shown the qualntity and class of the Ig that could be eluted from 10 nml of the various sera by means of the specific immunoadsorbenlts. The results are expressed as milligramiis per 100 ml of the seruml saml)le. An anti-IgM of the IgG class could be de- tected in the sera of all A-AGG patients but not froml those of I-AGG. The percentage of IgG in the eluted material ranged between 2.1 andI 10% of the total IgG in the serum. Sera from the three patienits with I-AGG and from two patients with A-AGG who had anaphylactic-like reactions following GG and/or plasma therapy slhowed detectable quantities of anti-IgA of the IgG class. (1, 8) . In human blood there is a mlixture of B and T cells (2, 14) . The majority of receptors carried by the blood are of the IgG class and the nminority are of IgM class (10, 14) . Work from several laboratories had shown that the B cell originates from the bursa of Fabricius in the chicken (15) and probably from the bone marrow in the mouse (16) and man (1) . The B cells originating from these central ly)mphoid organs undergo successive maturation steps prior to acquisition of the capacity of secreting Ig (15, 17) . Recent studies dealing with the ontogeny of the B system have indicated that IgMI carrying cells are the first to appear in mice (7) , chicken (17) , and man (18) . Administration of anti-IL-chain antisera in the neonatal period in either the mouse or chicken model resulted in suppression of B cell differentiation with subsequent AGG in adult life (6, 7) . Circulating anti-Ichain antisera were detected in these animals.
There had been recent interest in searching for circulating anti-Ig that could play a role in the pathogenesis of several lymphoproliferative (12, 19, 20) and autoimmune diseases (21) . Several patients with selective IgA deficiency were found to have in their serum anti-IgMI of the IgG class (22, 23) . Recently a high titer anti-IgG of the IgMI class was detected in a patient with AGG with recurrent infections (24) . In a recent study anti-IgM antibodies were detected in 23.8% of 18 patients with various types of immunodeficiencies (25) . The role the anti-Ig plays in the pathogenesis of these diseases is not clear at the present time. In all these studies no attempt was made to study the biological significance of these anti-Igs.
In this study we have shown that in I-AGG the cell defect is due to the absolute lack of B cells in both bone marrow (29, 30) . This could be attributed to the heterogeneity of this group of patients and/or to the severity of their disease. More work is needed to look for the variables in this disease and for possible B cell defects at various levels of maturation following their emigration from the central lymphoid compartment. This study and several other recent publications (6, 12, 17, 24) will help in the understanding of clinical disease states associated with abnormal B cell function. Defects at one or more of the maturation steps of the stem cell to mature B cells have to be considered in antibody deficiency states. At the present there is an urgent need to understand the factor (s) that control B cell differentiation, stem cell-microenvironment interaction and those that influence the migration of B cells from the central lymphoid organ to the periphery.
